Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Impact of Initiating Biologics in Patients With Severe Asthma on Long-Term Oral Corticosteroids or Frequent Rescue Steroids (GLITTER): Data From the International Severe Asthma Registry
Wenjia Chen, Trung N. Tran, Mohsen Sadatsafavi, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 9, pp. 2732-2747
Open Access | Times Cited: 18

Showing 18 citing articles:

Effects of biological therapies on patients with Type-2 high asthma and comorbid obesity
Diya Garg, Loretta G. Que, Jennifer L. Ingram
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 9
Unlocking the Long-Term Effectiveness of Benralizumab in Severe Eosinophilic Asthma: A Three-Year Real-Life Study
Laura Pini, Diego Bagnasco, Bianca Beghè, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 10, pp. 3013-3013
Open Access | Times Cited: 9
Connections and Unmet Needs: Severe Asthma Biologics and Osteoporosis
Fabiana Furci, Marco Umberto Scaramozzino, Giuseppe Rocco Talesa, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 197-197
Open Access | Times Cited: 1
WHAT WE KNOW TO DATE ABOUT EARLY TREATMENT WITH BIOLOGICS IN SEVERE ASTHMA
Luis Pérez de Llano, Mary Ann Bonilla, Elisa Luzón, et al.
Open Respiratory Archives (2025) Vol. 7, Iss. 2, pp. 100418-100418
Open Access
Long-term, real-world effectiveness of biologics for severe uncontrolled asthma: The PROSPECT study
Kazuhisa Asai, Takashi Iwanaga, Mai Takahashi, et al.
Respiratory Investigation (2025) Vol. 63, Iss. 3, pp. 444-452
Open Access
Biologics in severe asthma: the role of real-world evidence from registries
Giovanni Paoletti, J. Pepys, Marta Casini, et al.
European Respiratory Review (2022) Vol. 31, Iss. 164, pp. 210278-210278
Open Access | Times Cited: 21
Unlocking the Long-Term Effectiveness of Benralizumab in Severe Eosinophilic Asthma: A Three-Year Real-Life Study
Laura Pini, Diego Bagnasco, Bianca Beghè, et al.
(2024)
Open Access | Times Cited: 3
Difficult-To-Treat and Severe Asthma: Can Real-World Studies On Effectiveness of Biological Treatments Change the Lives of Patients?
Corrado Pelaia, Antonio Giacalone, Gianluca Ippolito, et al.
Pragmatic and Observational Research (2024) Vol. Volume 15, pp. 45-51
Open Access | Times Cited: 2
Real‐world biologics response and super‐response in the International Severe Asthma Registry cohort
Eve Denton, Mark Hew, Matthew Peters, et al.
Allergy (2024) Vol. 79, Iss. 10, pp. 2700-2716
Open Access | Times Cited: 2
Disease Burden and Access to Biologic Therapy in Patients with Severe Asthma, 2017–2022: An Analysis of the International Severe Asthma Registry
Tham Le, David Price, Clement Erhard, et al.
Journal of Asthma and Allergy (2024) Vol. Volume 17, pp. 1055-1069
Open Access | Times Cited: 2
Impact of pre-biologic impairment on meeting domain-specific biologic responder definitions in patients with severe asthma
Luis Pérez de Llano, Ghislaine Scélo, Giorgio Walter Canonica, et al.
Annals of Allergy Asthma & Immunology (2023) Vol. 132, Iss. 5, pp. 610-622.e7
Open Access | Times Cited: 4
Exploring the long-term effects of biologic initiation in severe asthma: Insights from the International Severe Asthma Registry
I. K. P. Cheng, Su‐Boon Yong, James Cheng‐Chung Wei
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 2, pp. 535-536
Open Access | Times Cited: 1
Expert consensus on oral corticosteroids stewardship for the treatment of severe asthma in the Middle East and Africa
Mona Al‐Ahmad, Ashraf Al Zaabi, Ashraf Madkour, et al.
Respiratory Medicine (2024) Vol. 228, pp. 107674-107674
Closed Access | Times Cited: 1
Biologic Super-Response and Clinical Remission in Severe Asthma
Eve Denton, Mark Hew
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 9, pp. 2713-2714
Open Access | Times Cited: 2
Reply to “Exploring the long-term effects of biologic initiation in severe asthma: Insights from the International Severe Asthma Registry”
Wenjia Chen, Trung N. Tran, Mohsen Sadatsafavi, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 2, pp. 536-539
Open Access
Immunogenicity of biologics used in the treatment of asthma
Omario A.M. Neunie, Wardah Rabbani, David Baker, et al.
Human Antibodies (2024) Vol. 32, Iss. 3, pp. 121-128
Closed Access
Understanding Differential Response to Biologic Therapies in Severe Asthma: Retrospective study
Laila Salameh, Fatema Abdulkarim, Maitha Hammadi, et al.
Medical Research Archives (2024) Vol. 12, Iss. 3
Open Access
Asthma registries: Tedious paperwork or a versatile tool for the generation of knowledge—Insights from the Australasian Severe Asthma Registry (ASAR)
Erin S. Harvey, Matthew Peters
Respirology (2023) Vol. 28, Iss. 11, pp. 986-988
Open Access
Pulmonology for the rhinologist
Raewyn G. Campbell, Titus Auyeung, Gregory Katsoulotos
Current Opinion in Otolaryngology & Head & Neck Surgery (2023) Vol. 32, Iss. 1, pp. 20-27
Closed Access
Page 1

Scroll to top